H. Balachandran

发表

Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge

T. Kepler, B. Korber, H. Liao, 2017, Nature Communications.

Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens.

B. Korber, J. Mascola, S. Santra, 2012, Virology.

SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

A. Sette, G. Maddern, D. Lynn, 2022, Cell Reports Medicine.

COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection

D. Lynn, D. Weiskopf, S. Turville, 2021, medRxiv.

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients

H. Jäck, A. Kelleher, M. Sobti, 2022, bioRxiv.

Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection

A. Kelleher, S. Turville, R. Bull, 2021, Cell Reports Medicine.

Zika virus protection by a single low dose nucleoside modified mRNA vaccination

D. Weissman, Laura L. Sutherland, B. Haynes, 2017, Nature.

Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses

G. Ahlenstiel, T. Sorrell, A. Kelleher, 2022, Cell Reports.

Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost

B. Korber, H. Liao, Laura L. Sutherland, 2015, Journal of Virology.

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients

H. Jäck, A. Kelleher, M. Sobti, 2022, bioRxiv.

Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.

S. Santra, N. Letvin, J. Custers, 2009, Vaccine.

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability

H. Jäck, A. Kelleher, K. J. Jackson, 2021, Immunity.

Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib

A. Verma, S. Parmar, L. Platanias, 2009, Leukemia & lymphoma.

Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates

B. Korber, H. Liao, Laura L. Sutherland, 2018, Journal of Virology.

Vaccination Reduces Simian-Human Immunodeficiency Virus Sequence Reversion through Enhanced Viral Control

M. Lifton, N. Letvin, E. Manuel, 2010, Journal of Virology.

Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes.

J. Sodroski, B. Haynes, D. Burton, 2015, Virology.

Cross-reactive potential of human T-lymphocyte responses in HIV-1 infection.

B. Korber, B. Haynes, S. Santra, 2014, Vaccine.

Mosaic Vaccines Elicit CD8+ T lymphocyte Responses in Monkeys that Confer Enhanced Immune Coverage of Diverse HIV Strains

James Theiler, Norman L. Letvin, Bette T. Korber, 2010, Nature Medicine.

Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates

S. Santra, M. Lifton, N. Letvin, 2012, Vaccine.

Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

B. Moss, D. Montefiori, S. Santra, 2016, Open forum infectious diseases.

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

M. Hudgens, J. Mascola, D. Montefiori, 2011, Science Translational Medicine.

High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019

F. Luciani, G. Ahlenstiel, Dominic Michael Dwyer, 2022, Immunology and cell biology.

Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.

D. Montefiori, J. Schmitz, N. Letvin, 2010, Blood.

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques

H. Liao, B. Haynes, D. Montefiori, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections.

Brennan S. Dirk, N. Letvin, Yong Gao, 2016, Virology.

Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses

B. Haynes, W. Jacobs, N. Letvin, 2009, Journal of Virology.

'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19

S. Barry, A. Sette, G. Maddern, 2021, SSRN Electronic Journal.

Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates

B. Korber, Laura L. Sutherland, B. Haynes, 2018, Journal of Virology.

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

M. Hudgens, J. Mascola, D. Montefiori, 2011, Science Translational Medicine.

Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques

B. Haynes, D. Montefiori, S. Santra, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Vectors Prime for Strong Cellular Responses to Simian Immunodeficiency Virus Gag in Rhesus Macaques

B. Haynes, John P. Miller, W. Jacobs, 2014, Clinical and Vaccine Immunology.

Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses

B. Haynes, W. Jacobs, N. Letvin, 2009, Journal of Virology.

Recombinant Bacillus Calmette-Guérin vectors prime for strong cellular responses

B. Haynes, John P. Miller, M. Lifton, 2014 .